ABSTRACT
An improved microextraction method is proposed on the basis of ultrasound-assisted surfactant-enhanced emulsification and solidiï¬cation of a ï¬oating organic droplet procedure combined with high performance liquid chromatography for the preconcentration and quantification of alprazolam (ALP) and chlordiazepoxide (CHL) present in a number of human serum samples. Several parameters affecting the extraction efficiency were investigated by the Plackett -Burman factorial design as the screening design. Then the response surface methodology based on the Box-Behnken design was used to optimize the effective parameters in the proposed procedure. The limits of detection for the proposed method were found to be 3.0 and 3.1 ng mL-1 for CHL and ALP, respectively. The calibration curves obtained for the method were linear in the ranges of 10.0-3,500.0 and 10.0-3,000.0 ng mL-1 for CHL and ALP, respectively, with a good determination coefficient. The recoveries of the drugs in the spiked human serum samples were above 93.0%. The developed method was successfully applied to the analysis of these studied drugs in human serum samples. The pre-treatment of the serum samples was performed using acetonitrile to remove the proteins. The proposed procedure was an accurate and reliable one for the determination and preconcentration of these drugs in blood samples.
Subject(s)
Alprazolam/blood , Chlordiazepoxide/blood , Chromatography, High Pressure Liquid/methods , Liquid Phase Microextraction/methods , Sonication/methods , Humans , Limit of Detection , Linear Models , Reproducibility of ResultsABSTRACT
A new approach based on the ultrasound-assisted reversed-phase dispersive liquid-liquid microextraction technique is developed for the extraction and determination of vitamin A and vitamin E from oil matrices before high-performance liquid chromatography analysis. A methodology based on the full factorial design is carried out to choose the significant parameters. Then the significant factors affecting the extraction efficiency including pH, volume of extraction solvent, and volume of disperser solvent are optimized using a Box-Behnken design. After analyzing the results obtained, the optimum conditions were: pH 4.5, 80-20 µL of the ethanol/water solvent mixture as extraction solvent, 110 µL of 1,4-dioxane as the disperser solvent, and a sonication time of 10 min. For validation of the developed method, the linear dynamic range, repeatability, limit of detection, and recoveries were obtained under the optimum conditions. The detection limits of the method were 1.6 and 2.3 ng/mL for vitamin A and vitamin E, respectively. The extraction recovery percentages for the studied drugs were above 91%, with acceptable relative standard deviation. The proposed methodology was successfully applied for the determination of the vitamins in different oil samples.
ABSTRACT
A simple, sensitive, and rapid microextraction method, namely, ultrasound-assisted surfactant-enhanced emulsification microextraction based on the solidification of floating organic droplet method coupled with high-performance liquid chromatography was developed for the simultaneous preconcentration and determination of nitrazepam and midazolam. The significant parameters affecting the extraction efficiency were considered using Plackett-Burman design as a screening method. To obtain the optimum conditions with consideration of the selected significant variables, a Box-Behnken design was used. The microextraction procedure was performed using 29.1 µL of 1-undecanol, 1.36% (w/v) of NaCl, 10.0 µL of sodium dodecyl sulfate (25.0 µg mL(-1)), and 1.0 µL of Tween80 (25.0 µg mL(-1)) as an emulsifier in an extraction time of 20.0 min at pH 7.88. In order to investigate the validation of the developed method, some validation parameters including the linear dynamic range, repeatability, limit of detection, and recoveries were studied under the optimum conditions. The detection limits of the method were 0.017 and 0.086 ng mL(-1) for nitrazepam and midazolam, respectively. The extraction recovery percentages for the drugs studied were above 91.0 with acceptable relative standard deviation. The proposed methodology was successfully applied for the determination of these drugs in a number of human serum samples.
